AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending August 2015; Reports Consolidated Earnings Results for the First Quarter Ended November 30, 2014; Provides Earnings Guidance for the Six Months Period Ending on February 2015 and Year Ending August 31, 2015
January 09, 2015 at 10:20 am EST
Share
AFC-HD AMS Life Science Co., Ltd. provided dividend guidance for the second quarter and full year ending August 2015. For the quarter, the company expects dividend of JPY 5.00 per share.
For the year 2015, the company expects dividend of JPY 5.00 per share.
The company reported consolidated earnings results for the first quarter ended November 30, 2014. For the period, the company reported net sales of JPY 3,371 million against JPY 3,455 million a year ago. Operating income was JPY 173 million against JPY 218 million a year ago. Ordinary income was JPY 166 million against JPY 201 million a year ago. Net income was JPY 99 million or JPY 8.37 diluted per share against JPY 129 million or JPY 10.92 per share a year ago.
The company provided earnings guidance for the six months period ending on February 2015 and year ending August 31, 2015. For the six months, the company expects net sales of JPY 14,000 million, operating income of JPY 750 million, ordinary income of JPY 700 and net income of JPY 400 or JPY 33.67 per share.
For the year, the company expects net sales of JPY 7,000 million, operating income of JPY 330 million, ordinary income of JPY 300 and net income of JPY 170 or JPY 14.31 per share.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending August 2015; Reports Consolidated Earnings Results for the First Quarter Ended November 30, 2014; Provides Earnings Guidance for the Six Months Period Ending on February 2015 and Year Ending August 31, 2015
AFC-HD AMS LIFE SCIENCE CO., LTD. 
